ANEB · Anebulo Pharmaceuticals, Inc. · Documents
Market Cap
$13.46M
Shares
40.78M
Volume · Mar 2
21.4K
Avg daily vol (3M)
99.57K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-02-12 | — | |
| 10-Q | 2026-02-12 | 2025-12-31 | |
| 8-K | 2026-02-06 | 2026-02-05 | |
| 8-K | 2026-01-29 | — | |
| 8-K | 2026-01-27 | 2026-01-26 | |
| 8-K | 2025-12-22 | — | |
| 10-Q | 2025-11-13 | 2025-09-30 | |
| 8-K | 2025-11-13 | — | |
| 8-K | 2025-09-29 | — | |
| 10-K | 2025-09-29 | 2025-06-30 | |
| 8-K | 2025-09-12 | — | |
| 8-K | 2025-07-23 | — | |
| 8-K | 2025-05-13 | — | |
| 10-Q | 2025-05-13 | 2025-03-31 | |
| 8-K | 2025-04-15 | 2025-04-11 | |
| 8-K | 2025-04-14 | 2025-04-11 | |
| 8-K | 2025-04-07 | 2025-04-04 | |
| DEF 14A | 2025-03-06 | — | |
| 8-K | 2025-02-24 | 2025-02-20 | |
| 10-Q | 2025-02-14 | 2024-12-31 | |
| 8-K | 2025-02-14 | — | |
| 8-K | 2025-02-12 | 2025-02-11 | |
| 8-K | 2024-12-23 | 2024-12-22 | |
| 8-K | 2024-11-13 | — | |
| 10-Q | 2024-11-13 | 2024-09-30 | |
| 8-K | 2024-10-17 | — | |
| 10-K | 2024-09-25 | 2024-06-30 | |
| 8-K | 2024-09-25 | — | |
| 8-K | 2024-07-22 | — | |
| 8-K | 2024-06-17 | 2024-06-13 | |
| 8-K | 2024-05-15 | — | |
| 10-Q | 2024-05-15 | 2024-03-31 | |
| 10-Q | 2024-02-13 | 2023-12-31 | |
| 8-K | 2024-02-13 | — | |
| 8-K | 2023-11-21 | 2023-11-20 | |
| 8-K | 2023-11-14 | — | |
| 10-Q | 2023-11-14 | 2023-09-30 | |
| DEF 14A | 2023-10-30 | — | |
| 8-K | 2023-10-06 | 2023-10-05 | |
| 8-K | 2023-09-29 | 2023-09-26 | |
| 10-K | 2023-09-22 | 2023-06-30 | |
| 8-K | 2023-09-20 | — | |
| 8-K | 2023-09-05 | 2023-08-29 | |
| 10-Q | 2023-05-11 | 2023-03-31 | |
| 8-K | 2023-05-11 | — | |
| 8-K | 2023-04-11 | — | |
| 8-K | 2023-03-28 | — | |
| 8-K | 2023-03-08 | 2023-03-02 | |
| 10-Q | 2023-02-10 | 2022-12-31 | |
| 8-K | 2023-02-10 | — |
Showing 1–50 of 76 filings